Effect of methotrexate and omega-3 combination on cytogenetic changes of bone marrow and some enzymatic antioxidants : an experimental study

Abstract EN

Objective: This study aimed to assess the effect of methotrexate and omega-3 combination on cytogenetic changes of bone marrow and activities of some enzymatic antioxidants.

Methods: Fifty-six mature male Wistar rats were divided into two experimental groups and a control group.

The first experimental group was sub-divided into three sub-groups depending on concentration of methotrexate (MTX): X1 (0.05 mg/kg MTX), X2 (0.125 mg/kg MTX) and X3 (0.250 mg/kg MTX), which were given intraperitoneally on a weekly basis for eight weeks.

The second experimental group (MTX and omega-3 group) was also sub-divided into three sub-groups (Y1, Y2 and Y3), which were injected intraperitoneally with 0.05, 0.125 and 0.25 mg/kg MTX, respectively, weekly for eight weeks accompanied by the oral administration of 300 mg/kg omega-3..

The rats of the control group were given distilled water.

The enzymatic activity of catalase (CAT), superoxide dismutase (SOD) and glutathione reductase (GR) were measured in the sera of rats.

In addition, the mitotic index (MI) and chromosomal aberrations of bone marrow were also studied.

Results: MTX resulted in a significant decrease in the activities of CAT, SOD and GR compared to the controls.

It also led to an increase in the MI and chromosomal aberrations of rat bone marrows.

On the other hand, omega-3 significantly increased the activities of the investigated enzymatic antioxidants and reduced the MI and chromosomal aberrations in treated mice when given in combination with MTX.

Conclusions: MTX has a genotoxic effect on the bone marrow by increasing the MI and all types of chromosomal aberrations and decreases the enzymatic activity of CAT, SOD and GR.

The addition of omega-3 leads to a protective effect by reducing the toxic and mutagenic effects of MTX.